← back to search

Yan Lü

Hebei Medical University · CN
Area of research
Cancer Research · Epidemiology
Research interest
Research interests include Cervical Cancer and HPV Research, MicroRNA in disease regulation, Cancer-related molecular mechanisms research, and Estrogen and related hormone effects.
h-index
35
citations
4,247
works
391
NIH funding
primary concept
email

Recent publications

Tapia syndrome following anterior cervical surgery in a patient with diffuse idiopathic skeletal hyperostosis: a case report
Frontiers in Surgery 2026cited by 1position: firstdoi
Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Asian Patients With Moderate to Severe Psoriasis: Improvements in Patient‐Reported Outcomes in a Randomized Trial
The Journal of Dermatology 2025cited by 3position: middledoi
Rapidly progressive interstitial lung disease risk prediction in anti-MDA5 positive dermatomyositis: the CROSS model
Frontiers in Immunology 2024cited by 24position: middledoi
Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial
Journal of the American Academy of Dermatology 2024cited by 21position: middledoi
Deucravacitinib, an oral selective allosteric tyrosine kinase 2 inhibitor, in patients from China mainland, Taiwan and South Korea with moderate-to-severe plaque psoriasis: a phase III randomized clinical trial
British Journal of Dermatology 2024cited by 13position: middledoi
A review on the current literature regarding the value of exosome miRNAs in various diseases
Annals of Medicine 2023cited by 29position: middledoi
Pyruvate dehydrogenase beta subunit (Pdhb) promotes peripheral axon regeneration by regulating energy supply and gene expression
Experimental Neurology 2023cited by 27position: middledoi
Gender differences in patients with anti-MDA5-positive dermatomyositis: a cohort study of 251 cases
Clinical Rheumatology 2023cited by 14position: middledoi
Contribution of m5C RNA Modification-Related Genes to Prognosis and Immunotherapy Prediction in Patients with Ovarian Cancer
Mediators of Inflammation 2023cited by 6position: middledoi
A novel microRNA panel exhibited significant potential in evaluating the progression of laryngeal squamous cell carcinoma
Non-coding RNA Research 2023cited by 5position: middledoi
Correction: Circular RNA circCORO1C promotes laryngeal squamous cell carcinoma progression by modulating the let-7c-5p/PBX3 axis
Molecular Cancer 2023cited by 2position: middledoi
Correction: Circular RNA circCORO1C promotes laryngeal squamous cell carcinoma progression by modulating the let-7c-5p/ PBX3 axis
Molecular Cancer 2023cited by 2position: middledoi
Identification of Three Different Phenotypes in Anti–Melanoma Differentiation–Associated Gene 5 Antibody–Positive Dermatomyositis Patients: Implications for Prediction of Rapidly Progressive Interstitial Lung Disease
Arthritis & Rheumatology 2022cited by 93position: middledoi
Coexistence of Anti-Ro52 Antibodies in Anti-MDA5 Antibody–Positive Dermatomyositis Is Highly Associated With Rapidly Progressive Interstitial Lung Disease and Mortality Risk
The Journal of Rheumatology 2022cited by 55position: middledoi
Time-dependent changes in RPILD and mortality risk in anti-MDA5+ DM patients: a cohort study of 272 cases in China
Lara D. Veeken 2022cited by 47position: middledoi
Biological roles and clinical significance of estrogen and androgen receptors in head and neck cancers
Journal of Cancer 2022cited by 19position: middledoi
Guidelines for Diagnosis and Treatment of Atopic Dermatitis in China (2020)#
International Journal of Dermatology and Venereology 2021cited by 33position: middledoi
Crosstalk between RNA m6A Modification and Non-coding RNA Contributes to Cancer Growth and Progression
Molecular Therapy — Nucleic Acids 2020cited by 76position: middledoi
Early-onset androgenetic alopecia in China: a descriptive study of a large outpatient cohort
Journal of International Medical Research 2020cited by 31position: middledoi
Non-coding RNAs in drug resistance of head and neck cancers: A review
Biomedicine & Pharmacotherapy 2020cited by 29position: middledoi
<p>miR-424-5p Promotes Proliferation, Migration and Invasion of Laryngeal Squamous Cell Carcinoma</p>
OncoTargets and Therapy 2019cited by 55position: middledoi
Identification of miR‐145‐5p‐Centered Competing Endogenous RNA Network in Laryngeal Squamous Cell Carcinoma
PROTEOMICS 2019cited by 21position: middledoi
Discovery of an Orally Bioavailable Inhibitor of Defective in Cullin Neddylation 1 (DCN1)-Mediated Cullin Neddylation
Journal of Medicinal Chemistry 2018cited by 61position: middledoi
Papulosquamous Diseases
2018cited by 4position: middledoi
Breastfeeding and the Risk of Maternal Cardiovascular Disease: A Prospective Study of 300 000 Chinese Women
Journal of the American Heart Association 2017cited by 118position: middledoi
Hsa-miR-301a-3p Acts as an Oncogene in Laryngeal Squamous Cell Carcinoma via Target Regulation of Smad4
Journal of Cancer 2015cited by 43position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Wei Gao · Hebei Medical University9 papers (2015–2023)Yongyan Wu · Shenzhen University8 papers (2019–2023)Shuxin Wen · The Ohio State University Wexner Medical Center7 papers (2015–2023)Xiwang Zheng · Shenzhen University6 papers (2019–2023)Huizheng Li · Dalian Medical University6 papers (2019–2023)Min Niu · Royal College of Surgeons in Ireland5 papers (2019–2023)Yujia Guo · Guangzhou University of Chinese Medicine4 papers (2020–2023)Yunfeng Bo · Shanxi Medical University4 papers (2019–2023)Fengsheng Dai · Shanxi Medical University4 papers (2020–2023) · 4 papers (2020–2023)Linshi Zhang · Zhejiang University4 papers (2020–2023)Xuting Xue · Southwest University4 papers (2019–2023)Yuliang Zhang · Nanchang University4 papers (2019–2023)Rui Hou · Air Force Medical University3 papers (2020–2023)Li Dai · Dalian Medical University3 papers (2020–2023)Huina Guo · Shanxi Medical University3 papers (2019–2023)Wenqi Li · Oregon Health & Science University3 papers (2023–2023)Wei Xu · Shandong University3 papers (2020–2023)Shuping Guo · Shanxi Medical University2 papers (2024–2025)Binquan Wang · Shihezi University2 papers (2019–2019)